OpenAlex
PricingAboutJobs
Log inGet started
Work

Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy

HTML

Year: 2015
Type: review
Source: Journal of Controlled Release
DOI: 10.1016/j.jconrel.2015.08.056
Author: Marina A. Dobrovolskaia
Institutions: Frederick National Laboratory for Cancer Research, National Cancer Institute, Leidos Biomedical Research Inc. (United States)
Language: English

Topic: Nanoparticle-Based Drug Delivery
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Keywords: nanomedicine, preclinical drug development, hematologic toxicity, endotoxin detection, endotoxin removal, physicochemical characterization, sterilization, depyrogenation, clinical translation of nanomedicine
SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute
Awards: G386607036, G5888954722
OpenAlex ID: W1698993839
FWCI: 1.245
Cites: 142
Cited by: 245
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms